All In MedTech

Device Trial Radar · NCT00686647

AngioSculpt® Coronary Bifurcation Study

AngioSculpt® Scoring Balloon Catheter Multi-Center Coronary Bifurcation Study

Last checked: Nov 20, 2026Latest source record: Aug 10, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

93

Actual

Start

Apr 2008

Primary completion

Apr 2010

Study completion Jan 2011

Sponsor

Lead sponsor
AngioScore, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 30, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate a new angioplasty catheter, AngioSculpt® for the treatment of bifurcation lesions (blockages occurring at branch points) in coronary arteries.

Conditions

  • Coronary Artery Disease
  • Myocardial Ischemia

Interventions

  • AngioSculpt® Scoring Balloon CatheterDevice

    Use of a stent for the main branch of a bifurcation lesion and use of a scoring balloon for the side branch of the same bifurcation lesion

  • AngioSculpt Scoring Balloon CatheterDevice

    Treatment of the side-branch vessel of true bifurcation lesions using the AngioSculpt device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedural SuccessTime frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Columbia University Medical Center

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.